Video

Building a legacy of innovation in biotechnology and drug discovery

As drug discovery grows more complex, the pace of discovery increasingly depends on the tools and people working behind the scenes.
Written byYuning Wang, PhD and BPS Bioscience
| 1 min read
Building a legacy of innovation in biotechnology and drug discovery


Drug discovery often moves at the speed of the tools behind it. As therapeutic approaches have become more sophisticated, researchers have increasingly relied on specialized, validated systems to test ideas faster and generate results with greater confidence.

In this Shaping Science episode, Veronique Baron shares how her team at BPS Bioscience has built and evolved research tools to keep pace with changing scientific questions, from early enzyme work to platforms supporting next-generation therapies.

Watch this episode to explore:

  • How scientists identify gaps in research workflows and turn them into practical, usable tools
  • What it’s like to work in a scientist-driven organization where learning, creativity, and collaboration are part of everyday work
  • How close partnerships between tool developers and researchers help accelerate discovery in fast-moving fields
Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Yuning Wang

    Yuning joined the custom content team at Drug Discovery News in June 2022. She earned her PhD in biochemistry from the University of Western Ontario, where she investigated how calcium sensor proteins regulate muscle cell membrane repair and cause muscular dystrophy. Yuning developed a passion for science communication during graduate school and began her career as a science writer in 2020. She enjoys reading, gardening, and trying new restaurants in Toronto.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in a white lab coat looking into a microscope in a brightly lit modern laboratory.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue